ER-100 epigenetic therapy: Clinical Trials

1 trial of ER-100 epigenetic therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow ER-100 epigenetic therapy: new trials by email Literature Review of ER-100 epigenetic therapy trials Research Report on ER-100 epigenetic therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
ER-100 epigenetic therapy - Open Angle Glaucoma (OAG), NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)
Phase 1RecruitingLife Biosciences Inc.182026-03-022026-05-19

Conditions studied

Glaucoma, Open-Angle (1)  ·  Optic Nerve Diseases (1)  ·  Retinal Diseases (1)

Sponsors

Life Biosciences Inc. (1)

Countries

United States (1)

Top investigators

Sharon Rosenzweig-Lipson, PhD (1)